The purpose of this study was to develop a test to discriminate between women suffering from pelvic pain associated with presence or absence of endometriosis, using symptom visual analogue scale (VAS) scores, demographic and lifestyle factors and known and novel plasma biomarkers.
Methods
This was a prospective cohort study. We recruited women presenting with pelvic pain symptoms and undergoing laparoscopy. They provided a plasma sample and completed a questionnaire assessing symptom VAS scores, lifestyle factors and demographic details. Plasma was assayed for 18 potential biomarkers. Logistic regression was used to develop a test to discriminate between women with pelvic pain associated with presence or absence of endometriosis.
Results
A series of 101 women were analyzed. On univariate analysis, women with endometriosis were less likely to be parous or have previously used an intrauterine contraceptive device (IUD) but have a higher weekly alcohol intake. These women had higher VAS scores for nausea and dyspareunia, and higher plasma levels of cancer antigen 125 (CA-125). The optimum logistic regression model included parity, previous IUD use, history of endometriosis, weekly alcohol intake, dyspareunia, VAS score and CA-125. This model had a sensitivity of 93%, specificity of 62% and accuracy of 83%.
Conclusions
Combining symptom scores, historical measures and CA-125 provides a reasonable means to discriminate between women with pelvic pain associated with presence or absence of endometriosis, but greater specificity is needed before such a model could replace laparoscopy.
Get full access to this article
View all access options for this article.
References
1.
EskenaziB., WarnerM.L.Epidemiology of endometriosis. Obstet Gynecol Clin North Am.1997; 24(2): 235–258.
2.
GuoS.W., WangY.The prevalence of endometriosis in women with chronic pelvic pain. Gynecol Obstet Invest.2006; 62(3): 121–130.
3.
HealeyM., AngW.C., ChengC.Surgical treatment of endometriosis: a prospective randomized double-blinded trial comparing excision and ablation. Fertil Steril.2010; 94(7): 2536–2540.
4.
MettlerL., SchollmeyerT., Lehmann-WillenbrockE.. Accuracy of laparoscopic diagnosis of endometriosis. JSLS.2003; 7(1): 15–18.
5.
MarchinoG.L., GennarelliG., EnriaR., BongioanniF., LipariG., MassobrioM.Diagnosis of pelvic endometriosis with use of macroscopic versus histologic findings. Fertil Steril.2005; 84(1): 12–15.
6.
DeffieuxX., BallesterM., CollinetP., FauconnierA., PierreF.; French National College of Gynaecologists and Obstetricians. Risks associated with laparoscopic entry: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians. Eur J Obstet Gynecol Reprod Biol.2011; 158(2): 159–166.
7.
MagrinaJ.F.Complications of laparoscopic surgery. Clin Obstet Gynecol.2002; 45(2): 469–480.
8.
BallardK.D., SeamanH.E., de VriesC.S., WrightJ.T.Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study: Part 1. BJOG.2008; 115(11): 1382–1391.
9.
VodolazkaiaA., El-AalamatY., PopovicD.. Evaluation of a panel of 28 biomarkers for the non-invasive diagnosis of endometriosis. Hum Reprod.2012; 27(9): 2698–2711.
10.
Al-JefoutM., DezarnauldsG., CooperM.. Diagnosis of endometriosis by detection of nerve fibres in an endometrial biopsy: a double blind study. Hum Reprod.2009; 24(12): 3019–3024.
11.
FauconnierA., ChapronC.Endometriosis and pelvic pain: epidemiological evidence of the relationship and implications. Hum Reprod Update.2005; 11(6): 595–606.
12.
SinaiiN., PlumbK., CottonL.. Differences in characteristics among 1,000 women with endometriosis based on extent of disease. Fertil Steril.2008; 89(3): 538–545.
13.
FalconeT., LebovicD.I.Clinical management of endometriosis. Obstet Gynecol.2011; 118(3): 691–705.
14.
EskenaziB., WarnerM., BonsignoreL., OliveD., SamuelsS., VercelliniP.Validation study of nonsurgical diagnosis of endometriosis. Fertil Steril.2001; 76(5): 929–935.
15.
ChapronC., Pietin-VialleC., BorgheseB., DavyC., FoulotH., ChopinN.Associated ovarian endometrioma is a marker for greater severity of deeply infiltrating endometriosis. Fertil Steril.2009; 92(2): 453–457.
16.
MeulemanC., VandenabeeleB., FieuwsS., SpiessensC., TimmermanD., D'HoogheT.High prevalence of endometriosis in infertile women with normal ovulation and normospermic partners. Fertil Steril.2009; 92(1): 68–74.
17.
Kennedy S, Bergqvist A, Chapron C, et al; ESHRE Special Interest Group for Endometriosis and Endometrium Guideline Development Group. ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod.2005; 20(10): 2698–2704.
18.
OthmanE-D, HornungD., Al-HendyA.Biomarkers of endometriosis. Expert Opin Med Diagn.2008; 2(7): 741–752.
19.
MayK.E., Conduit-HulbertS.A., VillarJ., KirtleyS., KennedyS.H., BeckerC.M.Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update.2010; 16(6): 651–674.
20.
KajitaniT., MaruyamaT., AsadaH.. Possible involvement of nerve growth factor in dysmenorrhea and dyspareunia associated with endometriosis. Endocr J.2013; 60(10): 1155–1164.
21.
SuzumoriN., SuzumoriK.Peritoneal fluid concentrations of ciliary neurotrophic factor, a gp130 cytokine, in women with endometriosis. Gynecol Obstet Invest.2003; 56(1): 51–54.
22.
BrowneA.S., YuJ., HuangR.P., FranciscoA.M., SidellN., TaylorR.N.Proteomic identification of neurotrophins in the eutopic endometrium of women with endometriosis. Fertil Steril.2012; 98(3): 713–719.
23.
SeeberB., SammelM.D., FanX.. Proteomic analysis of serum yields six candidate proteins that are differentially regulated in a subset of women with endometriosis. Fertil Steril.2010; 93(7): 2137–2144.
24.
FalconerH., SundqvistJ., Gemzell-DanielssonK., von SchoultzB., D'HoogheT.M., FriedG.IVF outcome in women with endometriosis in relation to tumour necrosis factor and anti-Müllerian hormone. Reprod Biomed Online.2009; 18(4): 582–588.
25.
PrietoL., QuesadaJ.F., CamberoO.. Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis. Fertil Steril.2012; 98(1): 126–130.
26.
HsiehY.Y., ChangC.C., TsaiF.J., LinC.C., ChenJ.M., TsaiC.H.Glutathione S-transferase M1*null genotype but not myeloperoxidase promoter G-463A polymorphism is associated with higher susceptibility to endometriosis. Mol Hum Reprod.2004; 10(10): 713–717.
SinghA.K., ChattopadhyayR., ChakravartyB., ChaudhuryK.Markers of oxidative stress in follicular fluid of women with endometriosis and tubal infertility undergoing IVF. Reprod Toxicol.2013; 42: 116–124.
29.
AriciA., OralE., AttarE., TazukeS.I., OliveD.L.Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells. Fertil Steril.1997; 67(6): 1065–1072.
30.
VeillatV., SengersV., MetzC.N.. Macrophage migration inhibitory factor is involved in a positive feedback loop increasing aromatase expression in endometriosis. Am J Pathol.2012; 181(3): 917–927.
31.
ZhangX., XuH., LinJ., QianY., DengL.Peritoneal fluid concentrations of interleukin-17 correlate with the severity of endometriosis and infertility of this disorder. BJOG.2005; 112(8): 1153–1155.
32.
DanielY., GevaE., AmitA.. Do soluble cell adhesion molecules play a role in endometriosis?Am J Reprod Immunol.2000; 43(3): 160–166.
33.
Canis M, Donnez JG, Guzick DS, et al; American Society for Reproductive. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril.1997; 67(5): 817–821.
34.
VittinghoffE., McCullochC.E.Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol.2007; 165(6): 710–718.
35.
MihalyiA., GevaertO., KyamaC.M.. Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers. Hum Reprod.2010; 25(3): 654–664.
36.
SocolovR., ButureanuS., AngioniS.. The value of serological markers in the diagnosis and prognosis of endometriosis: a prospective case-control study. Eur J Obstet Gynecol Reprod Biol.2011; 154(2): 215–217.
37.
SomiglianaE., ViganòP., TirelliA.S.. Use of the concomitant serum dosage of CA 125, CA 19-9 and interleukin-6 to detect the presence of endometriosis. Results from a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions. Hum Reprod.2004; 19(8): 1871–1876.
38.
RosaE, SilvaACJS, RosaE, SilvaJ.C., FerrianiR.A.Serum CA-125 in the diagnosis of endometriosis. Int J Gynaecol Obstet.2007; 96(3): 206–207.
39.
KafaliH., ArtucH., DemirN.Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report. Eur J Obstet Gynecol Reprod Biol.2004; 116(1): 85–88.
40.
Barcena de ArellanoM.L., ArnoldJ., VercellinoG.F.. Influence of nerve growth factor in endometriosis-associated symptoms. Reprod Sci.2011; 18(12): 1202–1210.
41.
JangM.U., ParkJ.W., KhoH.S., ChungS.C., ChungJ.W.Plasma and saliva levels of nerve growth factor and neuropeptides in chronic migraine patients. Oral Dis.2011; 17(2): 187–193.
42.
Oner-IyidoğanY., KoçakH., GürdölF., KorkmazD., BuyruF.Indices of oxidative stress in eutopic and ectopic endometria of women with endometriosis. Gynecol Obstet Invest.2004; 57(4): 214–217.
43.
SzczepańskaM., KoźlikJ., SkrzypczakJ., MikołajczykM.Oxidative stress may be a piece in the endometriosis puzzle. Fertil Steril.2003; 79(6): 1288–1293.
44.
BurneyR.O., GiudiceL.C.Pathogenesis and pathophysiology of endometriosis. Fertil Steril.2012; 98(3): 511–519.
45.
OliveiraV.A., AbreuL.G., FerrianiR.A., ReisR.M., MouraM.D.Vascular endothelial growth factor in the plasma, follicular fluid and granulosa cells of women with endometriosis submitted to in vitro fertilization: a pilot study. Gynecol Endocrinol.2005; 20(5): 284–288.
46.
MatareseG., AlviggiC., SannaV.. Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J Clin Endocrinol Metab.2000; 85(7): 2483–2487.
47.
SeeberB., SammelM.D., FanX.. Panel of markers can accurately predict endometriosis in a subset of patients. Fertil Steril.2008; 89(5): 1073–1081.
48.
FujiiE.Y., NakayamaM., NakagawaA.Concentrations of receptor for advanced glycation end products, VEGF and CML in plasma, follicular fluid, and peritoneal fluid in women with and without endometriosis. Reprod Sci.2008; 15(10): 1066–1074.
GungorT., Kanat-PektasM., KarayalcinR., MollamahmutogluL.Peritoneal fluid and serum leptin concentrations in women with primary infertility. Arch Gynecol Obstet.2009; 279(3): 361–364.
51.
ShahD.K., CorreiaK.F., HarrisH.R., MissmerS.A.Plasma adipokines and endometriosis risk: a prospective nested case-control investigation from the Nurses’ Health Study II. Hum Reprod.2013; 28(2): 315–321.
52.
Drosdzol-CopA., Skrzypulec-PlintaV.Selected cytokines and glycodelin A levels in serum and peritoneal fluid in girls with endometriosis. J Obstet Gynaecol Res.2012; 38(10): 1245–1253.
53.
KocbekV., VoukK., MuellerM.D., RižnerT.L., BersingerN.A.Elevated glycodelin-A concentrations in serum and peritoneal fluid of women with ovarian endometriosis. Gynecol Endocrinol.2013; 29(5): 455–459.
54.
MatalliotakisI.M., GoumenouA.G., KoumantakisG.E.. Serum concentrations of growth factors in women with and without endometriosis: the action of anti-endometriosis medicines. Int Immunopharmacol.2003; 3(1): 81–89.
55.
GmyrekG.B., SozanskiR., JerzakM.. Evaluation of monocyte chemotactic protein-1 levels in peripheral blood of infertile women with endometriosis. Eur J Obstet Gynecol Reprod Biol.2005; 122(2): 199–205.
56.
AgicA., DjalaliS., WolflerM.M., HalisG., DiedrichK., HornungD.Combination of CCR1 mRNA, MCP1, and CA125 measurements in peripheral blood as a diagnostic test for endometriosis. Reprod Sci.2008; 15(9): 906–911.
57.
MorinM., BellehumeurC., TherriaultM.J., MetzC., MaheuxR., AkoumA.Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis. Fertil Steril.2005; 83(4): 865–872.
58.
KimJ.Y., KimH., SuhC.S., KimS.H., ChoiY.M., KimJ.G.The G(-2518)A polymorphism of monocyte chemotactic protein-1 (MCP-1) and its serum and peritoneal fluid levels in Korean women with endometriosis. Eur J Obstet Gynecol Reprod Biol.2008; 139(1): 106–110.
59.
SeeberB., SammelM.D., FanX.. Panel of markers can accurately predict endometriosis in a subset of patients. Fertil Steril.2008; 89(5): 1073–1081.
60.
VelascoI., AciénP., CamposA., AciénM.I., Ruiz-MaciáE.Interleukin-6 and other soluble factors in peritoneal fluid and endometriomas and their relation to pain and aromatase expression. J Reprod Immunol.2010; 84(2): 199–205.
61.
GrodsteinF., GoldmanM.B., RyanL., CramerD.W.Relation of female infertility to consumption of caffeinated beverages. Am J Epidemiol.1993; 137(12): 1353–1360.
62.
ChapronC., BarakatH., FritelX., DubuissonJ.B., BréartG., FauconnierA.Presurgical diagnosis of posterior deep infiltrating endometriosis based on a standardized questionnaire. Hum Reprod.2005; 20(2): 507–513.
63.
Nnoaham KE, Hummelshoj L, Kennedy SH, Jenkinson C, Zondervan KT; World Endometriosis Research Foundation Women's Health Symptom Survey Consortium. Developing symptom-based predictive models of endometriosis as a clinical screening tool: results from a multicenter study. Fertil Steril.2012; 98(3): 692–701, e5.
